Urology News and Research

Latest Urology News and Research

New study could bring hope to men who don't respond well to hormone therapy for prostate cancer

More than 1 million American have prostate cancer, the leading non-skin cancer in men in the United States. Last year alone some 220,000 new prostate cancer cases were reported, and 28,900 men died of it.

25 Jun 2004

New operating room with 3-dimensional technology that takes modern robotic surgery to new levels

Surgical teams are now performing robotic surgery for prostate cancer with enhanced efficiency, comfort and communication using this unique technology.

15 Jun 2004

Early hormone therapy for metastatic prostate cancer increases life expectancy

Men with aggressive, metastatic prostate cancer who receive immediate early hormone therapy live on average three to four years longer than others who delay similar treatment, according to researchers at the University of Rochester.

10 Jun 2004

Non-aspirin pain drugs may help men with recurrent prostate cancer

Early results from a University of North Carolina at Chapel Hill School of Medicine study may determine if drugs called Cox-2 inhibitors, a newer type of non-aspirin pain medicine now widely prescribed for arthritis symptoms, may benefit men with recurrent prostate cancer.

10 Jun 2004

Evidence that abnormally short telomeres play a role in the early development of cancer

Scientists at the Johns Hopkins Kimmel Cancer Center say they have evidence that abnormally short telomeres - the end-caps on chromosomes that normally preserve genetic integrity -appear to play a role in the early development of many types of cancer.

27 May 2004

Prostate Robotic System that will improve the diagnosis and treatment of prostate cancer

The Singapore General Hospital and Nanyang Technological University (NTU) have jointly developed a Prostate Robotic System that will improve the diagnosis and treatment of prostrate cancer, the fifth most common cancer in Singaporean men.

21 May 2004

Physicians perceive overactive bladder as a normal part of aging when in fact it is a treatable medical condition

Nearly half of people with symptoms of overactive bladder had to initiate multiple conversations with their doctor before receiving a diagnosis or treatment, according to a national survey of more than 500 people with symptoms of overactive bladder. Furthermore, only 15 percent of those surveyed said their doctors had ever initiated a discussion about overactive bladder symptoms.

12 May 2004

Botox shows promise as an alternative treatment for benign prostatic hyperplasia

Injections of botulinum toxin A (botox) into the prostate are a promising alternative treatment for the millions of men who have benign prostatic hyperplasia (BPH), a condition commonly referred to as enlarged prostate, according to a study conducted by the University of Pittsburgh School of Medicine and Chang Gung Memorial Hospital in Taiwan.

11 May 2004

Sexual Dysfunction in benign prostatic hyperplasia (BPH) twice as high as physicians estimate

The incidence of sexual dysfunction in patients suffering from Benign Prostatic Hyperplasia (BPH) -- or enlarged prostate -- is nearly twice as high as treating physicians believe shows a new survey from the American Foundation for Urologic Diseases (AFUD) presented today at the American Urological Association annual meeting.

11 May 2004

Quality of life for men after prostate cancer treatment

Four to eight years after men undergo treatment for prostate cancer, they continue to see changes – both positive and negative – in their quality of life because of that treatment, researchers at the University of Michigan Health System and Harvard Medical School report.

11 May 2004

Risk of prostate cancer greater in men over 50 with high levels of testosterone

Men over 50 years of age with high blood levels of testosterone have an increased risk of prostate cancer, according to a study by researchers at Johns Hopkins and the National Institute on Aging. The finding throws some doubt on the safety of testosterone replacement therapy, the investigators say.

11 May 2004

Female incontinence and sexual dysfunction questions answered

Kristene Whitmore, M.D., an AUA spokesperson and director of the Pelvic Floor Institute at the Graduate Hospital in Philadelphia, will be on hand to answer reporter questions about incontinence and female sexual dysfunction on Sunday, May 9, 2004 at 3:00 p.m.

10 May 2004

Overweight post prostate cancer surgery patients have greater chance of cancer recurrence

After prostate cancer surgery, obese men are more likely than men with normal weight to have high levels of prostate specific antigen (PSA), a marker for cancer recurrence, according to a study led by Johns Hopkins researchers.

9 May 2004

Post surgery follow up by robotic physician

A new study at Johns Hopkins finds that many hospitalized patients prefer visits from their own physician to those of the physicians on duty, even when those "visits" are virtual "telerounds."

8 May 2004

FDA Approves PROSCAR® Combined With Doxazosin to Reduce the Risk of Benign Prostatic Hyperplasia Symptoms

Merck & Co., Inc. today announced that the Food and Drug Administration (FDA) has approved changes to the prescribing information for PROSCAR® (finasteride) based on a landmark National Institutes of Health (NIH) study.

20 Apr 2004

Two recent innovations look set to revolutionize biomedical treatment.

The first innovation is probably the world’s first multiple drug-eluting biodegradable stent for use in any part of the body where fluid flow, including blood, is disrupted.

19 Apr 2004

Bladder cancer is the fourth most common cancer in men and the eighth most common in women

Bladder cancer is the fourth most common cancer in men and the eighth most common in women, according to the National Cancer Institute (NCI). It is expected to be diagnosed in 38,000 men and 15,000 women in the United States in 2003. Treatment is most successful when the disease is caught early.

18 Apr 2004

Men with family history of prostate cancer accurately predict higher risk

When a man is diagnosed with prostate cancer, his brothers are twice as likely to develop the disease as well, often at an earlier age.

13 Apr 2004

New online prostate calculator

A study just completed by researchers at the Josephine Ford Cancer Center has resulted in the most comprehensive long-term prostate cancer survival model available to date. An interactive version of the survival model is available online at prostatecalculator.org.

12 Apr 2004

Kentucky's first robotic procedure treats prostate

Earlier this year, the University of Kentucky Hospital was the first hospital in Kentucky to perform a minimally invasive, coronary artery bypass graft using surgical robotic instruments.

12 Apr 2004

Urology News and Research

Latest Urology News and Research

New study could bring hope to men who don't respond well to hormone therapy for prostate cancer

New operating room with 3-dimensional technology that takes modern robotic surgery to new levels

Early hormone therapy for metastatic prostate cancer increases life expectancy

Non-aspirin pain drugs may help men with recurrent prostate cancer

Evidence that abnormally short telomeres play a role in the early development of cancer

Prostate Robotic System that will improve the diagnosis and treatment of prostate cancer

Physicians perceive overactive bladder as a normal part of aging when in fact it is a treatable medical condition

Botox shows promise as an alternative treatment for benign prostatic hyperplasia

Sexual Dysfunction in benign prostatic hyperplasia (BPH) twice as high as physicians estimate

Quality of life for men after prostate cancer treatment

Risk of prostate cancer greater in men over 50 with high levels of testosterone

Female incontinence and sexual dysfunction questions answered

Overweight post prostate cancer surgery patients have greater chance of cancer recurrence

Post surgery follow up by robotic physician

FDA Approves PROSCAR® Combined With Doxazosin to Reduce the Risk of Benign Prostatic Hyperplasia Symptoms

Two recent innovations look set to revolutionize biomedical treatment.

Bladder cancer is the fourth most common cancer in men and the eighth most common in women

Men with family history of prostate cancer accurately predict higher risk

New online prostate calculator

Kentucky's first robotic procedure treats prostate

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Urology News and Research

Latest Urology News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in